The aim of the study was to assess the effectiveness of the main classes of drugs used at reducing morbidity related to ureteric stents.

Treatment of Ureteral Stent-Related Symptoms

Pecoraro, Angela;Peretti, Dario;Aimar, Roberta;Niculescu, Gabriel;Alleva, Giorgio;Granato, Stefano;Sica, Michele;Amparore, Daniele;Checcucci, Enrico;Manfredi, Matteo;Fiori, Cristian;Porpiglia, Francesco
2021-01-01

Abstract

The aim of the study was to assess the effectiveness of the main classes of drugs used at reducing morbidity related to ureteric stents.
2021
1
16
Alpha antagonist; Antimuscarinic; Double J; International Prostate Symptom Score; Phosphodiesterase inhibitors; Quality of life; Ureteral Stent Symptom Questionnaire; Urinary symptoms
Pecoraro, Angela; Peretti, Dario; Tian, Zhe; Aimar, Roberta; Niculescu, Gabriel; Alleva, Giorgio; Piana, Alberto; Granato, Stefano; Sica, Michele; Amparore, Daniele; Checcucci, Enrico; Manfredi, Matteo; Karakiewicz, Pierre; Fiori, Cristian; Porpiglia, Francesco
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1881187
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact